EFCB5_HUMAN: A Potential Drug Target and Biomarker (G374786)

Target Name: EFCAB5

NCBI ID: G374786

EFCAB5

EFCB5_HUMAN: A Potential Drug Target and Biomarker

EFCB5_HUMAN, also known as EFCB5 human homolog 5, is a protein that is expressed in various tissues of the human body. It is a member of the EFCB5 family, which is characterized by the presence of a unique C-terminal domain that is involved in protein-protein interactions and other cellular processes. The EFCB5 gene has been identified in various human genomes, including the genomes of mouse, human, and several other organisms.

The EFCB5 gene has been associated with various cellular processes, including cell adhesion, migration, and invasion. It has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, EFCB5 has become a focus of interest for researchers studying the mechanisms underlying these diseases and for the development of potential therapeutic approaches.

EFCB5_HUMAN as a Drug Target

One potential approach to targeting EFCB5 in cancer therapy is to use small molecules that can modulate the activity of the EFCB5 protein. These small molecules can either inhibit or enhance the activity of EFCB5, depending on the desired effect on the cell. For example, some studies have shown that inhibitors of the EFCB5 protein have the potential to inhibit the growth of cancer cells.

In addition to its potential as a therapeutic agent, EFCB5 has also been identified as a potential biomarker for cancer. The EFCB5 protein is expressed in various tissues of the body, including the bloodstream, lymphatic system, and solid tissues. As a result, it has been suggested that EFCB5 could be used as a biomarker for cancer diagnosis or monitoring.

EFCB5_HUMAN as a Biomarker

The expression of EFCB5 in various tissues of the human body makes it an attractive candidate for use as a biomarker for cancer. EFCB5 is expressed in a variety of tissues, including the bloodstream, lymphatic system, and solid tissues. It is also highly expressed in cancer tissues, making it a potential indicator of the presence of cancer.

In addition to its potential as a biomarker, EFCB5 has also been shown to play a role in the development and progression of various diseases. For example, EFCB5 has been shown to be involved in the development of cancer, particularly ovarian cancer. Additionally, EFCB5 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In conclusion, EFCB5_HUMAN is a protein that has been shown to play a role in various cellular processes and has been associated with the development and progression of various diseases. As a result, it has potential as a drug target and biomarker for cancer and other diseases. Further research is needed to fully understand the role of EFCB5 in these processes and to develop effective therapeutic approaches.

Protein Name: EF-hand Calcium Binding Domain 5

The "EFCAB5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EFCAB5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets